Max India lost 0.58% to Rs 552.45 at 9:48 IST on BSE, with the stock sliding amid volatility after the company said that its board of directors approved to divest 23% stake in Max Bupa in favour of Bupa Plc., UK.
The announcement was made after market hours yesterday, 23 November 2015.
Meanwhile, the S&P BSE Sensex was up 17.20 points or 0.07% at 25,836.54.
On BSE, so far 14,000 shares were traded in the counter as against average daily volume of 35,500 shares in the past one quarter.
The stock was volatile. The stock fell as much as 0.65% at the day's low of Rs 552 so far during the day. The stock rose as much as 2.13% at the day's high of Rs 567.50 so far during the day. The stock had hit a record high of Rs 585.75 on 20 November 2015. The stock had hit a 52-week low of Rs 358.50 on 17 December 2014.
The stock had outperformed the market over the past one month till 23 November 2015, gaining 4.98% compared with Sensex's 6.01% fall. The scrip had also outperformed the market in past one quarter, rising 2.09% as against Sensex's 5.65% fall.
More From This Section
The large-cap company has equity capital of Rs 53.39 crore. Face value per share is Rs 2.
Bupa Plc, UK will pay Rs 191 crore (as increased by 23% of further capital infusions by shareholders in Max Bupa till the transaction is implemented) to Max India in an all cash transaction, to increase its stake in Max Bupa from 26% to 49%. Correspondingly, Max India's shareholding in Max Bupa will come down to 51% from the present level of 74%. The proposal is subject to the approval of Foreign Investment Promotion Board (FIPB) and Insurance Regulatory and Development Authority of India (IRDA), Max India said in a statement.
Further, the board also approved a capital contribution of up to Rs 150 crore by the company in Max Healthcare Institute, an equal joint venture between the company and Life Healthcare, South Africa, for its proportionate share of 46% equity stake in Max Healthcare, to enable Max Healthcare acquire a controlling stake of 51% in Saket City Hospitals, Max India said.
Meanwhile, the board of directors also took note of Embedded Value report as at 30 September 2015, shared by Max Life Insurance Company Limited (Max Life), its subsidiary. As per the report, the embedded value of Max Life as at 30 September 2015 is at Rs 5363 crore, after allowing for interim dividend payout of Rs 220 crore to the shareholders of Max Life. The annualised operating return on Embedded Value for the half year ended 30 September 2015 is at 14.8% and the annualised return is at 13.8%. The value of new business written during the half year ended 30 September 2015 is Rs 163 crore and the portfolio new business margin is 20.2% (before cost overrun) and 17% (after cost overrun), Max India said.
Max India reported net profit of Rs 2.74 crore in Q2 September 2015 compared with net loss of Rs 11.30 crore in Q2 September 2014. Total income rose 107.9% to Rs 30.98 crore in Q2 September 2015 over Q2 September 2014.
Max India is a multi-business company. The company offers life insurance, healthcare and health insurance services.
Powered by Capital Market - Live News